These case reports describe two patients with type 2 diabetes and chronic kidney disease who experienced acute kidney injury and worsening proteinuria shortly after initiating semaglutide, a GLP-1 receptor agonist. The authors recommend caution with using these agents in patients with moderate to severe CKD. The gene discussed is GLP1R; the disease is chronic kidney disease.